loading
전일 마감가:
$2.87
열려 있는:
$2.87
하루 거래량:
815.76K
Relative Volume:
0.79
시가총액:
$442.16M
수익:
$10.00M
순이익/손실:
$-29.47M
주가수익비율:
-14.25
EPS:
-0.2
순현금흐름:
$-21.55M
1주 성능:
-0.70%
1개월 성능:
-4.68%
6개월 성능:
-36.53%
1년 성능:
-19.49%
1일 변동 폭
Value
$2.78
$2.90
1주일 범위
Value
$2.78
$2.985
52주 변동 폭
Value
$2.525
$5.02

Mereo Biopharma Group Plc Adr Stock (MREO) Company Profile

Name
명칭
Mereo Biopharma Group Plc Adr
Name
전화
4403330237300
Name
주소
ONE CAVENDISH PLACE, LONDON
Name
직원
33
Name
트위터
@MereoBioPharma
Name
다음 수익 날짜
2024-09-05
Name
최신 SEC 제출 서류
Name
MREO's Discussions on Twitter

MREO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
MREO
Mereo Biopharma Group Plc Adr
2.85 442.16M 10.00M -29.47M -21.55M -0.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Mereo Biopharma Group Plc Adr Stock (MREO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-06 개시 Jefferies Buy
2024-06-13 개시 Robert W. Baird Outperform
2023-10-13 재개 BTIG Research Buy
2022-08-12 개시 Cantor Fitzgerald Overweight
2021-05-05 개시 BTIG Research Buy
2021-04-05 개시 Needham Buy
모두보기

Mereo Biopharma Group Plc Adr 주식(MREO)의 최신 뉴스

pulisher
Feb 06, 2025

Prepare Yourself for Liftoff: Mereo Biopharma Group Plc ADR (MREO) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

There is no doubt that OrganiGram Holdings Inc (OGI) ticks all the boxes. - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Check Out ImmunoPrecise Antibodies Ltd (IPA)’s Trade Data Rather Than the Analysts’ Views - SETE News

Feb 06, 2025
pulisher
Feb 04, 2025

Recent Insider Activity Could Benefit Mereo Biopharma Group Plc ADR (MREO) - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Analyzing Digital Turbine Inc (APPS) After Recent Trading Activity - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Market Insights: Mereo Biopharma Group Plc ADR (MREO)’s Notable Drop of -0.66, Closing at 2.99 - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Daily Market Movement: Twist Bioscience Corp (TWST) Sees a 0.73 Increase, Closing at 52.75 - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

In the Green: Sensata Technologies Holding Plc (ST) Closes at 25.62, Up/Down -5.67 from Previous Day - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

How should investors view Anavex Life Sciences Corporation (AVXL)? - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Health In Tech Inc (HIT) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Was there any good news for Mereo Biopharma Group Plc ADR (MREO) stock in the last session? - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

It would be worthwhile to take a closer look at Therealreal Inc (REAL) - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Lemonade Inc (LMND) deserves deeper analysis - US Post News

Feb 04, 2025
pulisher
Jan 15, 2025

symbol__ Stock Quote Price and Forecast - CNN

Jan 15, 2025
pulisher
Jan 13, 2025

Analyze Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Before Investing. - Stocks Register

Jan 13, 2025
pulisher
Jan 12, 2025

Mereo BioPharma Provides Update on Lead Clinical Programs - GlobeNewswire Inc.

Jan 12, 2025
pulisher
Jan 12, 2025

Mereo BioPharma's Setrusumab Advances Phase 3 Trial as Alvelestat Gains Key EU Support - StockTitan

Jan 12, 2025
pulisher
Dec 17, 2024

How Are Things Looking For Mereo Biopharma Group Plc ADR (NASDAQ: MREO) For The Short Term? - Stocks Register

Dec 17, 2024
pulisher
Dec 16, 2024

Crude Oil Down 1%; Webuy Global Shares Spike Higher - Benzinga

Dec 16, 2024
pulisher
Dec 15, 2024

Mereo BioPharma's SWOT analysis: rare disease pipeline drives stock potential - Investing.com

Dec 15, 2024
pulisher
Nov 25, 2024

Mereo BioPharma's SWOT analysis: rare disease stock poised for growth - Investing.com

Nov 25, 2024
pulisher
Nov 01, 2024

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN

Nov 01, 2024
pulisher
Oct 15, 2024

Do investors need to be concerned about Mereo Biopharma Group Plc ADR (MREO)? - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Mereo Biopharma Group Plc ADR (MREO) gets rating Initiated from Robert W. Baird - Knox Daily

Oct 14, 2024
pulisher
Oct 14, 2024

JP Morgan analysts upgrades an Overweight rating for Nucor Corp. (NUE) - Knox Daily

Oct 14, 2024
pulisher
Oct 14, 2024

KeyBanc Capital Markets initates Alignment Healthcare Inc (ALHC) stock to a Sector weight - Knox Daily

Oct 14, 2024
pulisher
Oct 09, 2024

Trading Day Review: Mereo Biopharma Group Plc ADR (MREO) Loses Momentum, Closing at 4.16 - The Dwinnex

Oct 09, 2024
pulisher
Oct 08, 2024

Natera Inc (NTRA) receives a Buy rating from Jefferies - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Barclays initates Reinsurance Group Of America, Inc. (RGA) stock to an Overweight - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Recent Insider Activity Suggests Potential Gains for Mereo Biopharma Group Plc ADR (MREO) - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Potential Price Increase for Portland General Electric Co (POR) After Recent Insider Activity - Knox Daily

Oct 08, 2024
pulisher
Oct 07, 2024

Analysts review KLA Corp.’s rating - Knox Daily

Oct 07, 2024
pulisher
Oct 07, 2024

Perhaps timely catching Mereo Biopharma Group Plc ADR (MREO) would be a good idea - SETE News

Oct 07, 2024
pulisher
Oct 04, 2024

MREO Stock Sees Surge of Approximately 7.32% in Last Five Days - Knox Daily

Oct 04, 2024
pulisher
Oct 03, 2024

Stocks of Mereo Biopharma Group Plc ADR (MREO) are poised to climb above their peers - SETE News

Oct 03, 2024
pulisher
Oct 01, 2024

Monitoring Mereo Biopharma Group Plc ADR (MREO) after recent insider movements - Knox Daily

Oct 01, 2024
pulisher
Oct 01, 2024

Mereo Biopharma Group Plc ADR (MREO)’s stock price in review: A technical analysis - US Post News

Oct 01, 2024
pulisher
Sep 30, 2024

Market Recap Check: Mereo Biopharma Group Plc ADR (MREO)’s Positive Finish at 4.14, Up/Down 0.98 - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Mereo Biopharma's SWOT analysis: rare disease biotech stock shows promise By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

Mereo Biopharma's SWOT analysis: rare disease biotech stock shows promise - Investing.com

Sep 30, 2024
pulisher
Sep 27, 2024

Mereo Biopharma Group Plc ADR [NASDAQ: MREO] Sees Increase in Stock Value - Knox Daily

Sep 27, 2024
pulisher
Sep 27, 2024

A Look at Mereo Biopharma Group Plc ADR (MREO) Shares in the Recent Past Indicates Growth - SETE News

Sep 27, 2024
pulisher
Sep 25, 2024

Examining Mereo Biopharma Group Plc ADR (MREO) more closely is necessary - US Post News

Sep 25, 2024
pulisher
Sep 24, 2024

Xylem Inc [XYL] stock was sold by Harker Victoria D at the price of US$0.35 million - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Chief Executive Officer, Scots-Knight Denise sold 60,046 shares of Mereo Biopharma Group Plc ADR [MREO] - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Verona Pharma Plc ADR [VRNA] President and CEO makes an insider sale of 600,000 shares worth $2.25 million. - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

MULN’s latest rating updates from top analysts. - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Truist analysts initates a Hold rating for Expedia Group Inc (EXPE) - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Closing Strong: Mereo Biopharma Group Plc ADR (MREO) Ends at 4.09, Down -3.76 from Last Close - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

Investing in Twist Bioscience Corp (TWST): What You Must Know - Knox Daily

Sep 24, 2024
pulisher
Sep 19, 2024

Canopy Growth Corporation [CGC] Shares Fall -2.45 % on Wednesday - Knox Daily

Sep 19, 2024

Mereo Biopharma Group Plc Adr (MREO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Mereo Biopharma Group Plc Adr 주식 (MREO) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Scots-Knight Denise
Chief Executive Officer
Sep 12 '24
Sale
4.47
28,611
127,968
868,967
Lewicki John A.
Chief Scientific Officer
Sep 13 '24
Sale
4.22
10,937
46,165
78,630
Lewicki John A.
Chief Scientific Officer
Sep 12 '24
Sale
4.47
5,212
23,312
89,567
Sermon Charles
General Counsel
Sep 13 '24
Sale
4.22
20,946
88,413
219,061
Sermon Charles
General Counsel
Sep 12 '24
Sale
4.47
9,980
44,638
240,007
Fox Christine Ann
Chief Financial Officer
Sep 13 '24
Sale
4.22
19,158
80,866
89,285
Fox Christine Ann
Chief Financial Officer
Sep 12 '24
Sale
4.47
9,128
40,827
108,443
Hughes-Wilson Alexandra
See Remarks
Sep 13 '24
Sale
4.22
100,312
423,417
50,475
Hughes-Wilson Alexandra
See Remarks
Sep 12 '24
Sale
4.47
47,798
213,786
150,787
Sermon Charles
General Counsel
Sep 11 '24
Option Exercise
0.00
65,600
0
249,987
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
자본화:     |  볼륨(24시간):